Therapeutic management of ocular adnexal MALT lymphoma

Bibliography

• SASAI K, YAMABE H, DODO Y et al.: Non Hodgkin’s lymphoma of the ocular adnexa. Acta Oncol. (2001) 40 (4):485-490.
   PubMed Web of Science ®Google Scholar
• SARRAF D, JAIN A, DUBOVY S et al.: Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina (2005) 25 (1):94-98.
   PubMed Web of Science ®Google Scholar
• HOLZ FG, BOEHMER HV, MECHTERSHEIMER G et al.: Uveal non-Hodgkin’s lymphoma with epibulbar extension simulating choroidal effusion syndrome. Retina (1999) 19 (4):343-346.
   PubMed Web of Science ®Google Scholar
• DECAUDIN D, DE CREMOUX P, VINCENT-SALOMON A et al.: Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood (2006) 108 :1451-1460.
   PubMed Web of Science ®Google Scholar
• MCKELVIE PA, MCNAB A, FRANCIS IC et al.: Ocular adnexa lymphoproliferative disease: a series of 73 cases. Clin. Experimental Opthalmol. (2001) 29 :387-393.
   PubMed Web of Science ®Google Scholar
• FUNG CY, TARBELL NJ, LUCARELLI MG et al.: Ocular adnexal lymphoma: clinical behaviour of distinct world health organization classification subtypes. Int. J. Radiat. Oncol. Biol. Phys. (2003) 57 :1382-1391.
   PubMed Web of Science ®Google Scholar
• FERRERI AJ, PONZONI M, GUIDOBONI M et al.: Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J. Natl Cancer Inst. (2006) 98 :1375-1381.
   PubMed Web of Science ®Google Scholar
• FARINHA P, GASCOYNE D: Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J. Clin. Oncol. (2005) 23 :6370-6378.
   PubMed Web of Science ®Google Scholar
• JAFFE ES: Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J. Natl Cancer Inst. (2004) 96 :571-573.
   PubMed Web of Science ®Google Scholar
• FERRERI AJM, GUIDOBONI M, PONZONI M et al.: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl Cancer Inst. (2004) 96 :586-594.
   PubMed Web of Science ®Google Scholar
• ROSADO MF, BYRNE JG, DING F et al.: Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood (2005) 107 :467-472.
   PubMed Web of Science ®Google Scholar
• VARGAS RL, FALLONE E, FELGAR RE et al.: Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Leuk. Res. (2005) 30 :547-551.
   PubMed Web of Science ®Google Scholar
• GRACIA E, MAZZUCCHELLI L, FROSCH L et al.: Low prevalence of Chlamydia psittaci infection in ocular adnexal lymphoma from Cuban patients. Ann. Oncol. (2005) 16 :303.
   Google Scholar
• DAIBATA M, NEMOTO Y, TOGITANI K et al.: Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients. Br. J. Haematol. (2006) 132 :651-661.
   PubMed Web of Science ®Google Scholar
• MULDER MMS, HEDDEMA ER, PANNEKOEK Y et al.: No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patient from the Netherlands. Leuk. Res. (2006) 32 :10305-10307.
   Google Scholar
• DE CREMOUX P, SUBTIL A, FERRERI AJ et al.: Low prevalance of Chlamydia psittaci infection in French patients with ocular adnexal lymphomas. J. Natl Cancer Inst. (2006) 98 :365-366.
   PubMed Web of Science ®Google Scholar
• CHANUDET E, ZHOU Y, BACON C et al.: Chlamydia psittaci is variably associated with ocular MALT lymphoma in different geographical regions. J. Pathol. (2006) 209 :344-351.
   PubMed Web of Science ®Google Scholar
• TANIMOTO K, KANEKO A, SUZUKI S et al.: Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann. Oncol. (2005) 17 :135-140.
   PubMed Web of Science ®Google Scholar
• MEUNIER J, LUMBROSO-LE ROUIC L, VINCENT-SALOMON A et al.: Ophthalmologic and intraocular non-Hodgkin’s lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors. Hematol. Oncol. (2004) 22 :143-158.
   PubMed Web of Science ®Google Scholar
• ESIK O, IKEDA H, MUKAI K et al.: A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin’s lymphomas. Radiother. Oncol. (1996) 38 :13-18.
   PubMed Web of Science ®Google Scholar
• LEE JL, KIM MK, LEE KH et al.: Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann. Hematol. (2005) 84 :13-18.
   PubMed Web of Science ®Google Scholar
• BALDINI L, BLINI M, GUFFANTI A et al.: Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann. Oncol. (1998) 9 :779-781.
   PubMed Web of Science ®Google Scholar
• MATSUO T, YOSHINO T: Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. Opthalmology (2004) 111 :1233-1237.
   PubMed Web of Science ®Google Scholar
• HARA Y, NAKAMURA N, KUZE T et al.: Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma. Invest. Ophthalmol. Vis. Sci. (2001) 42 :2450-2457.
   PubMed Web of Science ®Google Scholar
• BEN SIMON GJ, CHEUNG N, MCKELVIE P et al.: Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit. Ophthalmology (2006) 113 (7):1209-1213.
   PubMed Web of Science ®Google Scholar
• FERRERI AJM, PONZONI M, GUIDOBONI M et al.: Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J. Clin. Oncol. (2005) 23 :5067-5073.
   PubMed Web of Science ®Google Scholar
• REGUEIRO CA, VALCARCEL FJ, ROMERO J et al.: Treatment of conjunctival lymphomas by β-ray brachytherapt using a strontium-90-yttrium-90 applicator. Clin. Oncol. (2002) 14 :459-463.
   PubMed Web of Science ®Google Scholar
• ESSEL EM, HENK JM, WRIGHT JE et al.: Orbital and conjunctival lymphoma treatment and prognosis. Radiother. Oncol. (1988) 13 :237-244.
   PubMed Web of Science ®Google Scholar
• LIAO SL, KAO SC, HOU PK et al.: Results of radiotherapy for orbital and adnexal lymphoma. Orbit (2002) 21 :117-123.
   PubMedGoogle Scholar
• BHATIA S, PAULINO AC, BUATTI JM et al.: Curative radiotherapy for primary orbital lymphoma. Int. J. Radiat. Oncol. Biol. Phys. (2002) 54 :818-823.
   PubMed Web of Science ®Google Scholar
• STAFFORD SL, KOZELSKY TF, GARRITY JA et al.: Orbital lymphoma: radiotherapy outcome and complications. Radiother. Oncol. (2001) 59 :139-144.
   PubMed Web of Science ®Google Scholar
• LAU HY, CHUA ET, YANG TL et al.: Orbital lymphoma: results of radiation therapy. Ann Acad. Med. Singapore (1998) 27 :474-477.
   PubMedGoogle Scholar
• BOLEK TW, MOYSES HM, MARCUS RB et al.: Radiotherapy in the management of orbital lymphoma. Int. J. Radiat. Oncol. Biol. Phys. (1999) 44 :31-36.
   PubMed Web of Science ®Google Scholar
• ERKAL HS, SERIN M, SAK SD et al.: Radiation therapy for stage I primary orbital non-Hodgkin’s lymphomas. Tumori (1997) 83 :822-825.
   PubMed Web of Science ®Google Scholar
• WHITE WL, FERRY JA, HARRIS NL et al.: Ocular adnexal lymphoma: a clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Opthalmology (1995) 102 :1994-2006.
   PubMed Web of Science ®Google Scholar
• CHAO CK, LIN HS, DEVINENI VR et al.: Radiation therapy for primary orbital lymphoma. Int. J. Radiat. Oncol. Biol. Phys. (1995) 31 :929-934.
   PubMed Web of Science ®Google Scholar
• SMITT MC, DONALDSON SS: Radiotherapy is successful treatment for orbital lymphoma. Int. J. Radiat. Oncol. Biol. Phys. (1993) 26 :59-66.
   PubMed Web of Science ®Google Scholar
• LETSCHERT JG, GONZALEZ GONZALEZ D, OSKAM J et al.: Results of radiotherapy in patients with stage I orbital non-Hodgkin’s lymphoma. Radiother. Oncol. (1991) 22 :36-44.
   PubMed Web of Science ®Google Scholar
• VITU L, COSSET JM, BRIOT E et al.: Malignant non-Hodgkin’s lymphoma of the conjunctiva. Apropos of 14 cases treated at the Institut Gustave-Roussy. Bull. Cancer Radiother. (1990) 77 :61-68.
   PubMedGoogle Scholar
• VITU L, GIRINSKY T, BRIOT E et al.: Electron beam irradiation of conjunctival lymphomas. Int. J. Radiat. Oncol. Biol. Phys. (1991) 21 :1107-1108.
   PubMed Web of Science ®Google Scholar
• MARTINET S, OZSAHIN M, BELKACEMI Y et al.: Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. (2003) 55 :892-898.
   PubMed Web of Science ®Google Scholar
• EJIMA Y, SASAKI R, OKAMOTO Y et al.: Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother. Oncol. (2006) 78 :6-9.
   PubMed Web of Science ®Google Scholar
• UNO T, ISOBE K, SHIKAMA N et al.: Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa. Cancer (2003) 98 :865-871.
   PubMed Web of Science ®Google Scholar
• ZUCCA E, CONCONI A, PEDRINIS E et al.: Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood (2003) 101 :2489-2495.
   PubMed Web of Science ®Google Scholar
• HASEGAWA M, KOJIMA M, SHIOYA M et al.: Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int. J. Radiat. Oncol. Biol. Phys. (2003) 57 :172-176.
   PubMed Web of Science ®Google Scholar
• LE QT, EULAU SM, GEORGE T et al.: Primary radiotherapy for localized orbital MALT lymphoma. Int. J. Radiat. Oncol. Biol. Phys. (2002) 52 :657-663.
   PubMed Web of Science ®Google Scholar
• TSANG RW, GOSPODAROWICZ MK, PINTILIE M et al.: Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J. Clin. Oncol. (2003) 21 (22):4157-4164.
   PubMed Web of Science ®Google Scholar
• WENZEL C, FIEBIGER W, DIECKMANN K et al.: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area. Cancer (2003) 97 :2236-2241.
   PubMed Web of Science ®Google Scholar
• ZINZANI PL, STEFONI V, MUSURACA G et al.: Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer (2004) 100 (10):2190-2194.
   PubMed Web of Science ®Google Scholar
• JAGER G, NEUMEISTER P, BREZINSCHEK R et al.: Treatment of extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type with cladribine: a Phase II study. J. Clin. Oncol. (2002) 20 (18):3872-3877.
   PubMed Web of Science ®Google Scholar
• RADERER M, WOHRER S, BARTSCH R et al.: Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J. Clin. Oncol. (2005) 23 (33):8442-8446.
   PubMed Web of Science ®Google Scholar
• JAGER G, HOFLER G, LINKESCH W et al.: Occurence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica (2003) 88 (11):ECR01
   PubMedGoogle Scholar
• FERRERI AJ, PONZONI M, VIALE E et al.: Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications. Hematol. Oncol. (2006) 24 (1):33-37.
   PubMed Web of Science ®Google Scholar
• GRUNBERGER B, WOHRER S, STREUBEL B et al.: Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J. Clin. Oncol. (2006) 20 :1370-1375.
   Google Scholar
• GRUNBERGER B, HAUFF W, LUKAS J et al.: ‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann. Oncol. (2006) 17 :484-487.
   PubMed Web of Science ®Google Scholar
• ABRAMSON DH, ROLLINS I, COLEMAN M et al.: Periocular mucosa associated lymphoid/low grade lymphomas: treatment with antibiotics. Am. J. Ophtalmol. (2005) 140 :729-730.
   PubMed Web of Science ®Google Scholar
• FERRERI AJM, VIALE E, GUIDOBONI M et al.: Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann. Oncol. (2006) 17 :769-772.
   PubMed Web of Science ®Google Scholar
• VALLISA D, BERNUZZI P, ARCAINI L et al.: Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma: a multicenter italian experience. J. Clin. Oncol. (2005) 23 :468-473.
   PubMed Web of Science ®Google Scholar
• CONCONI A, MARTINELLI G, THIEBLEMONT C et al.: Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood (2003) 102 :2741-2745.
   PubMed Web of Science ®Google Scholar
• MARTINELLI G, LASZLO D, FERRERI AJ et al.: Clinical activity of rituximab in gastric marginal zone non-Hodgkin’s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J. Clin. Oncol. (2005) 20 :1979-1983.
   Google Scholar
• CELLINI M, POSSATI GL, PUDDU P et al.: Interferon alpha in the therapy of conjunctival lymphoma in an HIV+ patient. Eur. J. Ophthalmol. (1996) 6 :475-477.
   PubMedGoogle Scholar
• ZINZANI PL, MAGAGNOLI M, ASCANI S et al.: Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients. Ann. Oncol. (1997) 8 :883-886.
   PubMed Web of Science ®Google Scholar
• LACHAPELLE KR, RATHEE R, KRATKY V et al.: Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b. Arch. Ophthalmol. (2000) 118 :284-285.
   PubMed Web of Science ®Google Scholar
• BLASI MA, GHERLINZONI F, CALVISI G et al.: Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma. A preliminary report. Ophthalmology (2001) 108 :559-562.
   PubMed Web of Science ®Google Scholar
• LUCAS RS, MORTIMORE R, SULLIVAN TJ et al.: Interferon treatment of childhood conjunctival lymphoma. Br. J. Ophthalmol. (2003) 87 :1191.
   PubMed Web of Science ®Google Scholar
• ROSS JJ, TU KL, DAMATO BE et al.: Systemic remission of non-Hodgkin’s lymphoma after intralesional interferon alpha-2b to bilateral conjunctival lymphomas. Am. J. Opthalmol. (2004) 138 :672-673.
   PubMed Web of Science ®Google Scholar
• MOSLEHI R, DEVESA SS, SCHAIRER C et al.: Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J. Natl Cancer Inst. (2006) 98 :936-939.
   PubMed Web of Science ®Google Scholar
• NUCKEL H, MELLER D, STEUHL KP et al.: Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur. J. Haematol. (2004) 73 :258-262.
   PubMed Web of Science ®Google Scholar
• ZINZANI PL, ALINARI L, STEFONI V et al.: Rituximab in primary conjunctiva lymphoma. Leuk. Res. (2005) 29 :107-108.
   PubMed Web of Science ®Google Scholar
• SULLIVAN TJ, GRIMES D, BUNCE I: Monoclonal antibody treatment of orbital lymphoma. Opthal Plast. Reconstr. Surg. (2004) 20 :103-106.
   PubMed Web of Science ®Google Scholar
• ESMAELI B, MURRAY JL, AHMADI MA et al.: Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbit. Arch. Opthalmol. (2002) 120 :1225-1227.
   PubMedGoogle Scholar